Dihydroergotamine (injection)

Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about XXXXX, click here.

Synonyms / Brand Names:

Overview

Dihydroergotamine (injection)
Clinical data
ATC code
Pharmacokinetic data
Elimination half-life9 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC33H37N5O5
Molar mass583.678 g/mol




Dihydroergotamine is an ergot alkaloid used to treat migraines.


Category

FDA Package Insert

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Dihydroergotamine is an ergot alkaloid used to treat migraines.

"MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL]". </ref>

References

Template:Antimigraine preparations


Template:WH Template:WS